News

Post-transition guidance from the MHRA: Pharmacovigilance, QPPV and PSMF

On 01 September 2020, the Medicines and Healthcare products Regulatory Agency (MHRA) laid out the future UK requirements for submission of pharmacovigilance data at the end of the Brexit Transition period, as well as guidance on the qualified person responsible for pharmacovigilance (QPPV) and pharmacovigilance system master files (PSMF). Read more “Post-transition guidance from the MHRA: Pharmacovigilance, QPPV and PSMF”